Doris Wilder
Family Medicine · Sylvester, GANPI 1760476774
Payments from drug & device makers
Across 182 payments — averaging $15.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$586
- AbbVie$427
- Novo Nordisk$427
- Lilly USA, LLC$272
- Ironwood Pharmaceuticals, Inc$204
- AstraZeneca$175
- plus $777 from 14 others
What the payments were for
- Food & beverage$2,868100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 44 | $586 |
| AbbVie(2 entities) | 37 | $427 |
| Novo Nordisk | 25 | $427 |
| Lilly USA, LLC | 17 | $272 |
| Ironwood Pharmaceuticals, Inc | 12 | $204 |
| AstraZeneca | 11 | $175 |
| GSK | 8 | $174 |
| Johnson & Johnson | 6 | $116 |
| Viiv Healthcare Company | 1 | $107 |
| Sunovion Pharmaceuticals Inc. | 3 | $67 |
| Pfizer | 4 | $62 |
| Amgen | 3 | $48 |
| Bayer | 2 | $42 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $32 |
| Ardelyx, Inc. | 1 | $29 |
| Amarin Pharma, Inc. | 2 | $26 |
| Astellas Pharma US Inc | 1 | $25 |
| Abbott | 1 | $20 |
| Corcept Therapeutics | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $13 |
How this compares
$2,868 in reported general payments places this provider in the 75th percentile of 3,111 family medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 114 | $131,464 |
| EliquisApixaban | 94 | $106,536 |
| JardianceEmpagliflozin | 71 | $103,895 |
| JanuviaSitagliptin Phosphate | 75 | $91,650 |
| MounjaroTirzepatide | 62 | $67,734 |
| LinzessLinaclotide | 58 | $59,787 |
| RybelsusSemaglutide | 22 | $39,745 |
| FarxigaDapagliflozin Propanediol | 22 | $19,669 |
| XareltoRivaroxaban | 12 | $19,148 |
| Breo ElliptaFluticasone/Vilanterol | 25 | $16,360 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $14,908 |
| MyrbetriqMirabegron | 12 | $12,978 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 55 | $5,883 |
| Tresiba Flextouch U-100Insulin Degludec | 17 | $5,793 |
| Gabapentin | 286 | $5,608 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $427 | $171,209136 claims |
| PfizerEliquis | $62 | $106,53694 claims |
| Boehringer IngelheimJardiance | $586 | $103,89571 claims |
| Lilly USA, LLCMounjaro | $272 | $67,73462 claims |
| AbbVieLinzess | $427 | $59,78758 claims |
| GSKBreo Ellipta, Trelegy Ellipta | $174 | $31,26846 claims |
| AstraZenecaFarxiga | $175 | $19,66922 claims |
| Johnson & JohnsonXarelto | $116 | $19,14812 claims |
| Astellas Pharma US IncMyrbetriq | $25 | $12,97812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Sylvester
- Joseph SurberColumbus$16.6M
- Angela RitterGainesville$15.8M
- Jeffrey KingsleyColumbus$8.1M
- Christopher OldfieldSavannah$6.4M
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Debbie HaginsSavannah$2.1M
- Aziz PiraniLilburn$2.1M
- Nadia CameronAtlanta$2.1M
- John LentzSnellville$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.